Piramal Pharma Profile
Key Indicators
- Authorised Capital ₹ 3,000.00 Cr
as on 04-12-2024
- Paid Up Capital ₹ 1,325.75 Cr
as on 04-12-2024
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1,480.00 Cr
as on 04-12-2024
- Satisfied Charges ₹ 1,000.00 Cr
as on 04-12-2024
About Piramal Pharma
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543635.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3,000.00 Cr and a paid-up capital of Rs 1,325.75 Cr.
The company currently has active open charges totaling ₹1,480.00 Cr. The company has closed loans amounting to ₹1,000.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Piramal Pharma Limited India are Vivek Valsaraj as CFO and Tanya Dcosta as Company Secretary. Ramadorai Subramanian, Sridhar Gorthi, Jairaj Purandare, and Six other members serve as directors at the Company.
- CIN/LLPIN
L24297MH2020PLC338592
- Company No.
338592
- Stock Symbol
BSE : 543635
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2020
- Date of AGM
31 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Piramal Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Valsaraj  | CFO | 09-Feb-2021 | Current |
| Tanya Dcosta | Company Secretary | 10-Sep-2020 | Current |
Board Members(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Peter Stevenson  | Director | 30-Mar-2022 | Current |
| Peter Deyoung | Whole-Time Director | 04-Mar-2020 | Current |
| Jairaj Purandare | Director | 09-Feb-2021 | Current |
| Ramadorai Subramanian | Director | 09-Feb-2021 | Current |
| Sridhar Gorthi | Director | 30-Mar-2022 | Current |
| Nandini Piramal | Whole-Time Director | 04-Mar-2020 | Current |
Financial Performance of Piramal Pharma.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Piramal Pharma?
Unlock access to Piramal Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Icici Prudential Life Insurance Company LimitedActive 24 years 5 monthsVibha Rishi is a mutual person
Foundation For Promotion Of Sports And GamesActive 23 years 3 monthsNeeraj Bharadwaj is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Trusteeship Services Limited Creation Date: 12 Feb 2024 | ₹200.00 Cr | Open |
Idbi Trusteeship Services Limited Creation Date: 18 Dec 2023 | ₹130.00 Cr | Open |
Idbi Trusteeship Services Limited Creation Date: 24 May 2023 | ₹300.00 Cr | Open |
How Many Employees Work at Piramal Pharma?
Unlock and access historical data on people associated with Piramal Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Piramal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Piramal Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
